Prompt treatment is critical to slow the progression of wet AMD, a condition that can lead to severe vision loss. Over the past few decades, treatment options for wet AMD have advanced and treatment is now more effective 1. Treatment with an anti-VEGF is now the standard of care for wet AMD 1.
-
Gehrs KM, Anderson DH, Johnson LV, and Hageman GS. Age-related macular degeneration—emerging pathogenetic and therapeutic concepts. Ann Med. 2006; 38:450-471.
-
Kent C. Rev Ophthalmol 2009. Available at: https://www.reviewofophthalmology.com/article/macular-degeneration-is-laser-still-relevant
-
Brown DM, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two year results of the ANCHOR study. Ophthalmology 2009; 116:57-65.
-
Freund KB, et al. An update on the pharmacotherapy of neovascular age-related macular degeneration. Expert Opin Pharmacother. 2013; 14:1017-1028.
-
Holz FG, et al. Recent developments in the treatment of age-related macular degeneration. J Clin Invest. 2014; 124:1430-1438.
